Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva: Generic drug giant stumbles into NJ with $40M tax break from you
Teva Pharmaceuticals, News And Latest Headlines - I24NEWS
Teva enters opioid settlement agreement with US state Rhode Island
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
FDA approves first generic version of epilepsy drug Sabril from Teva
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Outsourcing active medicine ingredients leaves EU patients at risk
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
teva News and latest stories | The Jerusalem Post
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha